INDA vs XBI

iShares MSCI India ETF vs SPDR S&P Biotech ETF

Quick take
  • XBI has the lower expense ratio at 0.35% vs 0.61% for INDA.
  • XBI pays a higher dividend yield (0.36%).

Side-by-side metrics

MetricINDAXBI
Expense ratio
Annual fee. Lower is better.
0.61%0.35%
Dividend yield
Trailing 12-month yield.
0.00%0.36%
AUM
Assets under management — bigger funds are typically more liquid.
$6.87B$10.73B
YTD return
-9.99%33.79%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.561.10
P/E ratio
22.15
Last price
$49.10$164.01
Inception
Issuer
iSharesState Street

INDA top holdings

Top holdings · INDA
HDFCBANK.NSHDFC Bank Ltd6.53%
RELIANCE.NSReliance Industries Ltd6.09%
ICICIBANK.NSICICI Bank Ltd5.64%
BHARTIARTL.NSBharti Airtel Ltd3.87%
XTSLABlackRock Cash Funds Treasury SL Agency2.74%
INFY.NSInfosys Ltd2.42%
AXISBANK.BOAxis Bank Ltd2.33%
LT.NSLarsen & Toubro Ltd2.15%
M&M.NSMahindra & Mahindra Ltd2.08%
500034Bajaj Finance Ltd1.87%
Sector breakdown · INDA
Real Estate1.3%
Consumer Cyclical12.2%
Basic Materials8.5%
Consumer Defensive5.6%
Technology7.2%
Communication Services5.0%
Financial Services30.3%
Utilities4.2%
Industrials10.5%
Energy8.8%
Healthcare6.4%

XBI top holdings

Top holdings · XBI
APGEApogee Therapeutics Inc1.49%
MRNAModerna Inc1.41%
TWSTTwist Bioscience Corp1.41%
ORKAOruka Therapeutics Inc1.38%
KYMRKymera Therapeutics Inc Ordinary Shares1.36%
VKTXViking Therapeutics Inc1.30%
PRAXPraxis Precision Medicines Inc Ordinary Shares1.29%
ERASErasca Inc1.27%
RVMDRevolution Medicines Inc Ordinary Shares1.20%
RYTMRhythm Pharmaceuticals Inc1.20%
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%

About INDA

INDA (iShares MSCI India ETF) is Indian large- and mid-cap equities. Managed by iShares, the fund carries $6.9B in assets under management, an expense ratio of 0.61%. Its largest holding is HDFC Bank Ltd (HDFCBANK.NS), which represents 6.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.3%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.